Results 111 to 120 of about 13,620 (172)

Genetic Optimization of Early 2009 Pandemic H1N1 Vaccine Strains for Improved Replication in Embryonated Chicken Eggs. [PDF]

J Microbiol Biotechnol
Son SE, Song JH, An SH, Lee CY, Kim IH, Kim HW, Choi KS, Kwon HJ.   +7 more
europepmc   +1 more source

Phylogenetic Analysis of Highly Pathogenic Avian Influenza H7 Viruses in Australia and New Zealand Suggests Local Viral Evolution. [PDF]

Vet Sci
Silaban J, Ogada S, Naseem MN, Baek YH, Song MS, Ommeh SC.   +5 more
europepmc   +1 more source

Glycan masking in immunogen design: computational and experimental methods. [PDF]

Front Immunol
Araiza G, Morel J, Tran MH, Jiang S, Murray S, Miyamoto E, Vogts H, Brown KL, Meiler J, Martina CE.   +9 more
europepmc   +1 more source

Influenza C virus in humans and animals. [PDF]

Clin Exp Vaccine Res
Lee HS, Noh JY, Cheong HJ.
europepmc   +1 more source

Circulating Viral Antigenic Proteins and Inflammatory Biomarkers in Influenza and Respiratory Syncytial Virus Infections: Associations With Disease Severity and Transmission. [PDF]

Cureus
Chandra K, Das AK, Upadhyay B, Uddin A, Hussain SM, Islam F, Alvi Y, Gautam R, Kaur J, Khan S, Tewari R.   +10 more
europepmc   +1 more source

Broadly neutralizing monoclonal antibodies against influenza A viruses: current insights and future directions. [PDF]

Front Microbiol
Mahrous NN, Alhumaidan OS, Alkhoshaiban AS, Tafish RT, Al-Ghnnam FF, Althubyani M, Al-Hubaysh A, Jamous YF.   +7 more
europepmc   +1 more source

Pathogenicity and host range of avian influenza viruses: molecular determinants and virological perspectives. [PDF]

J Vet Med Sci
Ito T.
europepmc   +1 more source

Influenza Vaccines: Current Status, Adjuvant Strategies, and Efficacy. [PDF]

Vaccines (Basel)
Mokalla VR, Gundarapu S, Kaushik RS, Rajput M, Tummala H.   +4 more
europepmc   +1 more source

Incidence of Circulating Antibodies Against Hemagglutinin of Influenza Viruses in Epidemic Season 2023/2024 in Poland. [PDF]

Biomolecules
Kondratiuk K, Masny A, Poznańska A, Szymański K, Łuniewska K, Czajkowska E, Mańkowski B, Brydak LB.   +7 more
europepmc   +1 more source

Neutralizing activity against bovine H5N1 HPAIV (clade 2.3.4.4b) in human plasma after seasonal influenza vaccination. [PDF]

Emerg Microbes Infect
Zhang L, Behrens GMN, Kempf A, Nehlmeier I, Gärtner S, Moldenhauer AS, Graichen L, Happle C, Winkler M, Dopfer-Jablonka A, Pöhlmann S, Hoffmann M.   +11 more
europepmc   +1 more source